Analysts: BioMed Realty Trust Inc (BMR.N)

BMR.N on New York Stock Exchange

20.47USD
2:13pm EDT
Price Change (% chg)

$-0.19 (-0.92%)
Prev Close
$20.66
Open
$20.70
Day's High
$20.75
Day's Low
$20.47
Volume
121,530
Avg. Vol
513,293
52-wk High
$23.13
52-wk Low
$18.20

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.34 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 6 6 6 7
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.17 2.17 2.17 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 5 142.80 155.43 136.74 133.79
Quarter Ending Dec-13 5 144.47 155.24 136.74 135.21
Year Ending Dec-13 7 585.84 611.69 546.95 533.96
Year Ending Dec-14 8 606.75 666.69 552.42 549.58
Earnings (per share)
Quarter Ending Sep-13 10 0.34 0.35 0.32 0.34
Quarter Ending Dec-13 10 0.34 0.36 0.32 0.34
Year Ending Dec-13 11 1.48 1.52 1.38 1.36
Year Ending Dec-14 13 1.47 1.54 1.42 1.46
LT Growth Rate (%) 2 5.50 6.00 5.00 5.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 136.93 160.45 23.52 17.18
Quarter Ending Dec-12 134.71 138.77 4.06 3.01
Quarter Ending Sep-12 130.32 134.54 4.21 3.23
Quarter Ending Jun-12 122.31 124.85 2.53 2.07
Quarter Ending Mar-12 116.87 120.01 3.14 2.69
Earnings (per share)
Quarter Ending Mar-13 0.38 0.47 0.09 22.91
Quarter Ending Dec-12 0.34 0.33 0.01 3.65
Quarter Ending Sep-12 0.32 0.33 0.01 1.69
Quarter Ending Jun-12 0.29 0.32 0.03 9.66
Quarter Ending Mar-12 0.31 0.30 0.01 1.90

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 142.80 142.80 142.80 146.87 133.79
Quarter Ending Dec-13 144.47 144.47 144.47 148.19 135.21
Year Ending Dec-13 585.84 585.84 585.84 582.79 533.96
Year Ending Dec-14 606.75 606.75 606.75 611.29 549.58
Earnings (per share)
Quarter Ending Sep-13 0.34 0.34 0.34 0.34 0.34
Quarter Ending Dec-13 0.34 0.34 0.34 0.34 0.34
Quarter Ending Dec-13 1.48 1.48 1.46 1.49 1.36
Quarter Ending Dec-14 1.47 1.47 1.47 1.48 1.46

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 1 0
Year Ending Dec-13 0 0 1 0
Year Ending Dec-14 0 0 1 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Factual Report
$127.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks